Search results
3 days ago · Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions.
Jun 11, 2024 · CDC’s ACIP unanimously votes to add VAXELIS®, Sanofi and Merck’s pediatric hexavalent combination vaccine, to its preferential recommendations to help prevent invasive Hib disease in American Indian and Alaska Native infants. Read more. Jun 26, 2024.
Jan 9, 2024 · Press Release: Sanofi adds over €1 billion for biomanufacturing to €2.5 billion already committed in major projects in France to support health sovereignty. Read the Press Release. May 10, 2024.
4 days ago · Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The company provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, infections, central nervous system, anti-infectives, epilepsy, allergy and vitamins, and minerals and supplements, as well as pain care and nutritional ...
Jun 12, 2024 · At Sanofi, we are leaders in developing innovative treatments, driving collective action, strengthening healthcare ecosystems and mitigating our own impact. Paired with our global reach, disease expertise and the commitment of Sanofians around the world, we have the power and credibility to make a real difference in the future of our industry.
3 days ago · Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines.
5 days ago · Analyst Future Growth Forecasts. Earnings vs Savings Rate: SNY's forecast earnings growth (17% per year) is above the savings rate (2.4%). Earnings vs Market: SNY's earnings (17% per year) are forecast to grow faster than the US market (14.7% per year). High Growth Earnings: SNY's earnings are forecast to grow, but not significantly.
